Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khaled Barakat

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Chemico-Biological Interactions|March 8, 2024
Comparing the oxidative functions of neutrophil myeloperoxidase and cytochrome P450 enzymes in drug metabolismNewton H Tran, Farag E S Mosa, Khaled Barakat, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 20, 2019
Towards discovery of novel scaffold with potent antiangiogenic activity; design, synthesis of pyridazine based compounds, impact of hinge interaction, and accessibility of their bioactive conformation on VEGFR-2 activitiesMaiy Y Jaballah, Rabah A T Serya, Nasser Saad, et al.
Journal of Visualized Experiments : Jove|March 30, 2016
An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor InteractionsMohameedyaseen Syedbasha, Janina Linnik, Deanna Santer, et al.
Scientific Reports|November 14, 2018
Cyclosporine A binding to COX-2 reveals a novel signaling pathway that activates the IRE1α unfolded protein response sensorJody Groenendyk, Tautvydas Paskevicius, Hery Urra, et al.
Journal of Molecular and Cellular Cardiology|December 4, 2024
The sodium/glucose cotransporter 2 inhibitor Empagliflozin inhibits long QT 3 late sodium currents in a mutation specific mannerLynn C Lunsonga, Mohammad Fatehi, Wentong Long, et al.
Drug Development Research|July 12, 2024
Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugsFarag E S Mosa, Mohammed A Alqahtani, Mahmoud A El-Ghiaty, et al.
Archives of Biochemistry and Biophysics|July 11, 2024
Modulation of aryl hydrocarbon receptor activity by tyrosine kinase inhibitors (ponatinib and tofacitinib)Farag E S Mosa, Mohammed A Alqahtani, Mahmoud A El-Ghiaty, et al.
Bioorganic Chemistry|November 15, 2018
Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activityNevine M Y Elsayed, Rabah A T Serya, Mai F Tolba, et al.
Molecular and Cellular Biochemistry|July 12, 2023
16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanismRahmat Hidayat, Sherif M Shoieb, Farag E S Mosa, et al.
Swiss Medical Weekly|May 22, 2014
Vaccine adjuvants--understanding molecular mechanisms to improve vaccinesAdrian Egli, Deanna Santer, Khaled Barakat, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Chemico-Biological Interactions|March 8, 2024
Comparing the oxidative functions of neutrophil myeloperoxidase and cytochrome P450 enzymes in drug metabolismNewton H Tran, Farag E S Mosa, Khaled Barakat, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|December 20, 2019
Towards discovery of novel scaffold with potent antiangiogenic activity; design, synthesis of pyridazine based compounds, impact of hinge interaction, and accessibility of their bioactive conformation on VEGFR-2 activitiesMaiy Y Jaballah, Rabah A T Serya, Nasser Saad, et al.
Journal of Visualized Experiments : Jove|March 30, 2016
An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor InteractionsMohameedyaseen Syedbasha, Janina Linnik, Deanna Santer, et al.
Scientific Reports|November 14, 2018
Cyclosporine A binding to COX-2 reveals a novel signaling pathway that activates the IRE1α unfolded protein response sensorJody Groenendyk, Tautvydas Paskevicius, Hery Urra, et al.
Journal of Molecular and Cellular Cardiology|December 4, 2024
The sodium/glucose cotransporter 2 inhibitor Empagliflozin inhibits long QT 3 late sodium currents in a mutation specific mannerLynn C Lunsonga, Mohammad Fatehi, Wentong Long, et al.
Drug Development Research|July 12, 2024
Identification of aryl hydrocarbon receptor allosteric antagonists from clinically approved drugsFarag E S Mosa, Mohammed A Alqahtani, Mahmoud A El-Ghiaty, et al.
Archives of Biochemistry and Biophysics|July 11, 2024
Modulation of aryl hydrocarbon receptor activity by tyrosine kinase inhibitors (ponatinib and tofacitinib)Farag E S Mosa, Mohammed A Alqahtani, Mahmoud A El-Ghiaty, et al.
Bioorganic Chemistry|November 15, 2018
Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activityNevine M Y Elsayed, Rabah A T Serya, Mai F Tolba, et al.
Molecular and Cellular Biochemistry|July 12, 2023
16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanismRahmat Hidayat, Sherif M Shoieb, Farag E S Mosa, et al.
Swiss Medical Weekly|May 22, 2014
Vaccine adjuvants--understanding molecular mechanisms to improve vaccinesAdrian Egli, Deanna Santer, Khaled Barakat, et al.
Pageof 8